RX Green Fires Back at Mary's Medicinals

rx green marys medicinalsFollowing the press release issued yesterday by RX Green, it’s pretty clear that the Colorado cannabis company has been unable to patch up its differences with Mary’s Medicinals that we reported in late March. According to the company, it has filed a counter lawsuit in Denver District Court against Eleutherian Enterprises, the parent of Mary’s Medicinals, accusing it of “libel, slander, civil conspiracy, defamation, Consumer Protection Act violations and intentional interference with contractual relations.”

In March, Mary’s Medicinals stated that RX Green had engaged in “libel, slander, civil conspiracy, intentional interference with prospective business relations, and intentional interference with contractual relations.”  The company had suggested that the former owner, Joshua Meacham, had submitted fraudulent reports about Mary’s Medicinals to regulators and that RX Green misappropriated its website content.

RX Green has accused its competitor of spreading malicious rumors online, claiming that the sources are Nicole Smith, Founder and President, and COO Lynn Honderd, who were also named in the suit along with other employees. The company also alleged that it had cannabis products produced by Mary’s Medicinals tested at a certified laboratory that had “a fraction of the active ingredient tetrahydrocannabinol (THC) as advertised on the product labels.”

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter